Anacetrapib is not only able to increase HDL-cholesterol, but also further decreases LDL-cholesterol when taken in combination with a statin. Anacetrapib dose-dependently and significantly decreases the transfer of CE from HDL3 to HDL2. Anacetrapib doesn¡¯t affect the amount of [14C]-dalcetrapibthiol bound to rhCETP. Anacetrapib decreases pre-¦Â-HDL formation by more than 46%.Anacetrapib potently blocks CE and TG transfer in 95% human serum.

June 21, 2017

prudect name : Anacetrapib is not only able to increase HDL-cholesterol, but also further decreases LDL-cholesterol when taken in combination with a statin. Anacetrapib dose-dependently and significantly decreases the transfer of CE from HDL3 to HDL2. Anacetrapib doesn¡¯t affect the amount of [14C]-dalcetrapibthiol bound to rhCETP. Anacetrapib decreases pre-¦Â-HDL formation by more than 46%.Anacetrapib potently blocks CE and TG transfer in 95% human serum.
Anacetrapib (MK-0859)

Synonyms: Anacetrapib (MK-0859)CAS NO: 875446-37-0Molecular Formula: C₃₀H₂₅F₁₀NO₃Molecular Weight: 637.51Purity: 98% minSolubility: In DMSOStorage: -20°C

956697-53-3 References PubMed ID：:http://www.ncbi.nlm.nih.gov/pubmed/18502512